pf 1022a has been researched along with nitazoxanide in 1 studies
| Studies (pf 1022a) | Trials (pf 1022a) | Recent Studies (post-2010) (pf 1022a) | Studies (nitazoxanide) | Trials (nitazoxanide) | Recent Studies (post-2010) (nitazoxanide) |
|---|---|---|---|---|---|
| 33 | 1 | 5 | 573 | 85 | 352 |
| Protein | Taxonomy | pf 1022a (IC50) | nitazoxanide (IC50) |
|---|---|---|---|
| Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | 8.22 | |
| Signal transducer and activator of transcription 3 | Homo sapiens (human) | 9.89 | |
| Anoctamin-1 | Homo sapiens (human) | 0.424 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geary, TG; Sangster, NC; Thompson, DP | 1 |
1 review(s) available for pf 1022a and nitazoxanide
| Article | Year |
|---|---|
Frontiers in anthelmintic pharmacology.
Topics: Animals; Anthelmintics; Anti-Bacterial Agents; Anti-Infective Agents; ATP Binding Cassette Transporter, Subfamily B; Biological Availability; Caenorhabditis elegans; Cattle; Cattle Diseases; Depsipeptides; Diketopiperazines; Drug Resistance; Helminthiasis, Animal; Helminths; Ivermectin; Macrolides; Nitro Compounds; Peptides, Cyclic; Piperazines; Sheep; Sheep Diseases; Thiazoles | 1999 |